Egypt vs Saint Vincent and the Grenadines: HIV-positive TB patients on ART (antiretroviral therapy)
Egypt
100.0%
in 2024
Saint Vincent and the Grenadines
100.0%
in 2023
Egypt rank
1st
Saint Vincent and the Grenadines rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Egypt
- Saint Vincent and the Grenadines
How they compare
Egypt currently reports 100.0% against 100.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 3 times across 12 shared years of data; in 2006 it was Egypt ahead.
Egypt ranks 1st and Saint Vincent and the Grenadines ranks 1st of 144 countries.
Egypt has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Egypt | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 41.0% | 59.0% | Egypt |
| 2010s | 100.0% | 86.8% | 13.2% | Egypt |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Egypt or Saint Vincent and the Grenadines?
- Egypt, at 100.0% against 100.0% in Saint Vincent and the Grenadines as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Egypt and Saint Vincent and the Grenadines?
- 0.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and Saint Vincent and the Grenadines?
- 12 years are reported by both, from 2006 to 2023.
- How do Egypt and Saint Vincent and the Grenadines rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Egypt ranks 1st and Saint Vincent and the Grenadines ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.